Biotech RadarJobs updated

COMPANY

Immatics Biotechnologies

HQ: Stafford, TX (US office) source · immatics.com ↗

Clinical Phase 2

16 open jobs · last seen Oct 23, 2026 · 7 sources

Keywords: cell therapy oncology cancer Glioblastoma Metastatic Renal Cell Carcinoma Colorectal Carcinoma Renal Cell Carcinoma IMA402 IMA901 IMA950

Location: Stafford, TX (US office) · source · Oct 15, 2026

Profile checked Oct 10, 2026

16Open jobs7Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Facilities Technician II, HVACHoustonOct 21, 2026Oct 13, 2026
Principal Business Support SpecialistHoustonOct 21, 2026Oct 22, 2026
Quality Control Analyst IIHoustonOct 20, 2026Oct 21, 2026
Principal Manager, Clinical Operations Lead2 locations (listed on the posting)Oct 19, 2026Oct 20, 2026
Manager, Logistics - 2nd ShiftHoustonOct 13, 2026Oct 14, 2026

See all 16 jobs

Timeline

  1. Trial start Phase 1/Phase 2: IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors source ↗
  2. Trial start Phase 1: IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor source ↗
  3. Trial start I: GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients source ↗
  4. Trial start Phase 1: Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma source ↗
  5. Trial start Phase 3: IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma source ↗
  6. Trial start Phase 1/Phase 2: IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Ch source ↗
  7. Trial start Phase 2: IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 7

RecordTitlePhaseStatusStartPrimary completion
NCT05958121IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid TumorsPhase 1/Phase 2RecruitingAug 9, 20232027-09 (estimated)
NCT05359445IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint InhibitorPhase 1Active, not recruitingMay 19, 2022Mar 18, 2026 (actual)
NCT02149225GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma PatientsICompleted2014-102018-06 (actual)
NCT01265901IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell CarcinomaPhase 3Completed2010-122015-07 (actual)
NCT01403285Peptide-based Glioma Vaccine IMA950 in Patients With GlioblastomaPhase 1Terminated2011-082014-04 (actual)
NCT00785122IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)Phase 1/Phase 2Completed2008-062011-01 (actual)
NCT00523159IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable DiseasePhase 2Completed2007-052009-08 (actual)

Open jobs 16

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Facilities Technician II, HVACHoustonOct 21, 2026Oct 13, 2026Mid
Principal Business Support SpecialistHoustonOct 21, 2026Oct 22, 2026Not stated
Quality Control Analyst IIHoustonOct 20, 2026Oct 21, 2026Not stated
Principal Manager, Clinical Operations Lead2 locations (listed on the posting)Oct 19, 2026Oct 20, 2026Not stated
Manager, Logistics - 2nd ShiftHoustonOct 13, 2026Oct 14, 2026Senior
Senior Director, Manufacturing OperationsHoustonOct 13, 2026Oct 14, 2026Senior
Senior CMC Program ManagerHoustonOct 13, 2026Oct 14, 2026Senior
Vice President, Market Access2 locations (listed on the posting)Oct 5, 2026Oct 13, 2026Executive
Senior Director, Commercial Forecasting & Artificial Intelligence2 locations (listed on the posting)Sep 30, 2026Oct 13, 2026Senior
Senior Director, Medical Information2 locations (listed on the posting)Sep 28, 2026Oct 13, 2026Senior
Executive Director, IT Commercial2 locations (listed on the posting)Sep 25, 2026Oct 13, 2026Executive
Calibration/Maintenance Technician II, 2nd ShiftHoustonSep 23, 2026Oct 13, 2026Mid
Senior Facilities CoordinatorHoustonSep 23, 2026Oct 13, 2026Senior
Team Lead, Site Operations2 locations (listed on the posting)Sep 23, 2026Oct 13, 2026Senior
Validation Engineer IIHoustonSep 23, 2026Oct 13, 2026Mid
Senior Manager, Learning & Development2 locations (listed on the posting)Sep 22, 2026Oct 13, 2026Senior

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Connect

See your connections at Immatics Biotechnologies on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback